As an ER nurse working nights, it came to your attention in the last 3 days the markedly increased number of patients presenting with pulmonary edema, SOB, and cough. You are concerned about a chemical warfare agent.
Your best action is:

Choice A rationale

Compensated hypovolemic shock typically presents with tachycardia as the heart attempts to maintain cardiac output in the face of low volume. Furthermore, the skin is usually cool, pale, and clammy due to peripheral vasoconstriction. In this scenario, the patient is bradycardic with a heart rate of 45 beats/min and has warm, flushed skin, which directly contradicts the clinical presentation of hypovolemia where systemic vascular resistance would be elevated.

Choice B rationale

An allergic reaction or anaphylactic shock involves a massive release of histamine, leading to vasodilation and hypotension. While it can cause flushed skin, it is almost universally accompanied by tachycardia as the body compensates for the drop in blood pressure. The presence of significant bradycardia following a high cervical spine injury strongly points toward a neurological cause rather than an immunological trigger or a hypersensitivity response to an external allergen.

Choice C rationale

A cervical spine injury at C-5 can cause neurogenic shock by interrupting the sympathetic nervous system pathways. This results in loss of vasomotor tone, causing massive vasodilation and warm, flushed skin. Crucially, the loss of sympathetic input to the heart prevents tachycardia, leading to bradycardia despite hypotension. Normal heart rates range from 60 to 100 beats/min, and blood pressure should be around 120÷80 mm Hg, making these findings classic for neurogenic shock.

Choice D rationale

While warm skin can sometimes indicate a fever, the combination of profound hypotension and bradycardia in the context of a diving accident and potential spinal cord injury is pathognomonic for a circulatory collapse of neural origin. An elevated temperature alone would typically cause a compensatory increase in heart rate to meet the metabolic demands of the body. The primary concern here is the hemodynamic instability resulting from the spinal trauma.

Choice A rationale

Rest and watchful waiting are typically management strategies used for acute hepatitis A or sometimes acute hepatitis B, but they are not the standard of care for chronic hepatitis C. Chronic hepatitis C is a progressive viral infection that leads to liver fibrosis, cirrhosis, and hepatocellular carcinoma if left untreated. Because the virus continuously replicates and causes ongoing inflammatory damage to the hepatocytes, a passive approach is scientifically inadequate to prevent long term liver failure and mortality.

Choice B rationale

Immune globulins provide passive immunity and are used for post-exposure prophylaxis in hepatitis A or hepatitis B to prevent the development of an active infection. However, immune globulin has no proven efficacy in treating a well-established chronic hepatitis C infection. The hepatitis C virus has high genetic variability and undergoes rapid mutation, making it an ineffective target for standard immune globulin preparations. Treatment requires direct action against the viral replication cycle rather than a temporary immune boost.

Choice C rationale

Antiviral medications, specifically direct-acting antivirals, are the definitive treatment for chronic hepatitis C. These drugs work by targeting specific nonstructural proteins of the virus, such as NS3/4A, NS5A, or NS5B, which are essential for viral RNA replication and assembly. Modern regimens can achieve a sustained virologic response, which is effectively a cure, in over 95 percent of patients. Clearing the virus stops the progression of liver inflammation and allows the hepatic tissue to begin healing.

Choice D rationale

Fresh-frozen plasma is a blood product used to replace clotting factors in patients with severe coagulopathy or active bleeding, often seen in end-stage liver disease. While a patient with chronic hepatitis C might eventually need fresh-frozen plasma if they develop advanced cirrhosis and liver failure, it is not a treatment for the hepatitis C virus itself. It only manages the symptomatic complications of liver dysfunction rather than addressing the underlying viral etiology responsible for the hepatic damage.